SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-053249
Filing Date
2019-10-07
Accepted
2019-10-07 16:31:11
Documents
5
Period of Report
2019-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-19456_18k.htm 8-K 36160
2 EX-4.1 a19-19456_1ex4d1.htm EX-4.1 28693
3 EX-10.1 a19-19456_1ex10d1.htm EX-10.1 49279
4 EX-99.1 a19-19456_1ex99d1.htm EX-99.1 12504
5 GRAPHIC g194561mmi001.jpg GRAPHIC 3290
  Complete submission text file 0001104659-19-053249.txt   132789
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 191141171
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences